Clinical Trial Update: Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of cediranib with cilengitide in adults with progressive or recurrent glioblastoma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Cediranib (Cediranib)
• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Status: COMPLETED